Tuesday, March 17, 2020 10:09:26 PM
The first spinal surgery trials showed big promise but at the very end one patient died , but the death was totally unrelated to spinal surgery. The addition of nerve growth factors and/or stem cells could increase positive patient outcomes in the future. This should be a high priority area of research.
To start to have an effective treatment for paralysis in humans , where in the past there was no treatment at all, should be worth something, but the stock market sees little or no value in the Neural spinal scaffold (NSS) it seems.
How much more money will NVIV need to spend before completion of Inspire 2.0? Do the research medical centers bill NVIV for all the surgical costs and follow up care? Is it around 24 patients total?
Thanks.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM